Assistant Controller
BridgeBio
Assistant Controller
BridgeBio
Develops therapies for genetic diseases
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
What You’ll Do
The Senior Director, Assistant Controller is a key member of the accounting leadership team, reporting directly to the VP, Corporate Controller and serving as the VP Corporate Controller’s deputy for consolidation, close governance and accounting operations. This role is both technical and operational in nature, overseeing areas such as, but not limited to, consolidation and noncontrolling interest accounting, affiliate reporting and stand-alone audits, accounting systems and business processes, accounts payable, special projects, and BridgeBio’s overseas outsourced accounting team. The role also leads the accounting team’s desktop procedures program, process streamlining, and AI and automation agenda across all accounting functions. The role works closely with, but is separate from, the Technical Accounting and SEC Reporting function, which owns technical conclusions on complex and non-standard transactions as well as external financial reporting.
The role also partners with, rather than owns, revenue and cost accounting, R&D and sales & marketing accounting, payroll and stock compensation, tax, treasury, and the SOX program, which remain with their respective leaders.
The ideal candidate is a hands-on controllership leader with a strong technical foundation and a process-improvement mindset who is comfortable partnering with stakeholders across the organization. This individual thrives in a fast-paced, evolving commercial biotech environment, is agile in adapting to shifting priorities, and is equally effective managing day-to-day operations and leading process improvement, automation, and change management initiatives.
Responsibilities
Controllership: Close, Consolidation & Reporting Support
Close Governance & Financial Reporting:
Noncontrolling Interests & Consolidation:
Partnership with Technical Accounting and SEC Reporting:
Accounts Payable & T&E Operations Management:
Business Processes & Accounting Systems:
Manage Outsourced Accounting Team:
Desktop Procedures & Process Streamlining:
AI & Automation:
Partnership with Other Functions:
Ad Hoc Projects & Special Initiatives:
Where You’ll Work
This is a hybrid role requiring in-office collaboration at least 3 days per week at our San Francisco and/or Palo Alto offices.
Who You Are
Behavioral Characteristics
AI Requirements
As a global company, our comprehensive benefits may vary based on location. We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
For BridgeBio Full-Time U.S Based Roles:
Financial & Rewards
Health & Well-Being
Skill Development & Career Paths:
By applying, you acknowledge that BridgeBio will process your personal information as described in ourGlobal Candidate Privacy Notice.
Salary 240000 - 285000 USD
BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.
Explore more opportunities at BridgeBio